GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » EV-to-EBIT

SciBase Holding AB (OSTO:SCIB) EV-to-EBIT : -1.93 (As of May. 30, 2025)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SciBase Holding AB's Enterprise Value is kr127.91 Mil. SciBase Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr-66.25 Mil. Therefore, SciBase Holding AB's EV-to-EBIT for today is -1.93.

The historical rank and industry rank for SciBase Holding AB's EV-to-EBIT or its related term are showing as below:

OSTO:SCIB' s EV-to-EBIT Range Over the Past 10 Years
Min: -12.07   Med: -1.47   Max: 1.03
Current: -1.93

During the past 12 years, the highest EV-to-EBIT of SciBase Holding AB was 1.03. The lowest was -12.07. And the median was -1.47.

OSTO:SCIB's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 19.435 vs OSTO:SCIB: -1.93

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. SciBase Holding AB's Enterprise Value for the quarter that ended in Mar. 2025 was kr107.79 Mil. SciBase Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr-66.25 Mil. SciBase Holding AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -61.46%.


SciBase Holding AB EV-to-EBIT Historical Data

The historical data trend for SciBase Holding AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB EV-to-EBIT Chart

SciBase Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.15 -7.55 -5.84 -1.32 -1.36

SciBase Holding AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.52 -0.93 -1.42 -1.36 -1.63

Competitive Comparison of SciBase Holding AB's EV-to-EBIT

For the Medical Devices subindustry, SciBase Holding AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's EV-to-EBIT falls into.


;
;

SciBase Holding AB EV-to-EBIT Calculation

SciBase Holding AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=127.914/-66.245
=-1.93

SciBase Holding AB's current Enterprise Value is kr127.91 Mil.
SciBase Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-66.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB  (OSTO:SCIB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

SciBase Holding AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=-66.245/107.78932
=-61.46 %

SciBase Holding AB's Enterprise Value for the quarter that ended in Mar. 2025 was kr107.79 Mil.
SciBase Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-66.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB Headlines

No Headlines